Avidity Biosciences
RNA
#2710
Rank
ยฃ4.02 B
Marketcap
ยฃ33.77
Share price
-2.50%
Change (1 day)
607.60%
Change (1 year)

Avidity Biosciences (RNA) - Cash on Hand

Cash on Hand as of June 2024 : ยฃ1.03 Billion

According to Avidity Biosciences's latest financial reports the company has ยฃ1.03 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Avidity Biosciences - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31ยฃ0.46 B-7.43%
2022-12-31ยฃ0.50 B68.03%
2021-12-31ยฃ0.30 B24.8%
2020-12-31ยฃ0.24 B233.78%
2019-12-31ยฃ72.12 M2862.87%
2018-12-31ยฃ2.43 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ0.80 B-21.99%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ7.43 M-99.28%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.95 B-7.75%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.35 B-65.95%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.24 B-76.53%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ7.89 B 666.10%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.41 B 230.91%๐Ÿ‡ฌ๐Ÿ‡ง UK